Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Nanomedicine (Lond). 2010 Nov;5(9):1459–1466. doi: 10.2217/nnm.10.104

Figure 2. Simulation domain.

Figure 2

(A) Magnetic drug focusing in Phase I human clinical trials [1].

(B) We consider a single blood vessel (of any size, depth and blood velocity) and surrounding tissue and analyze the spatial distribution of magnetic particles.

(A) Adapted with permission from A Lübbe (Medical Center for Health, Bad Lippspringe, Germany).